This document defines peripartum cardiomyopathy (PPCM) as heart failure that occurs for the first time in the last month of pregnancy or within five months after delivery. It discusses the normal and abnormal cardiac findings, diagnostic criteria, incidence and risk factors, signs and symptoms, differential diagnosis, treatment, mode of delivery, prognosis, risk in subsequent pregnancies, length of treatment, and contraception considerations for patients with PPCM. The key points are that PPCM has an incidence of 1 in 4000 pregnancies, presents clinically in the third trimester or postpartum, and has a variable prognosis depending on initial left ventricular ejection fraction and degree of recovery.
Evaluation & Management Of Child With ArrhythmiasSalma Bashir
The management of a child in case of Bradycardia, Tachycardia, Irregular Rhythm, and V-tech. The all the details and treatment is shown in form of alogrithm and ECG's.
The following powerpoint presentation is about the current AF guidelines, prepared by Dr Jawad Siraj, who is a final year resident as Cardiology Unit, PGMI, LRH, Peshawar
Final presentation for my institutional APPE. I presented a full breakdown Cardiac Amyloidosis including clinical presentation, diagnosis and treatment options.
Cardiac arrhythmias occur frequently in ICU patients.
12% incidence of ventricular plus supra ventricular arrhythmias for a general icu population.
The most common arrhythmia is sinus tachycardia. Atrial arrhythmias also occur with some frequency , where as ventricular arrhythmias are less common but usually more ominous.
Not all arrhythmias seen in the ICU are of new onset , some patients have preexisting arrhythmias that can be exacerbated by their critical illness
Evaluation & Management Of Child With ArrhythmiasSalma Bashir
The management of a child in case of Bradycardia, Tachycardia, Irregular Rhythm, and V-tech. The all the details and treatment is shown in form of alogrithm and ECG's.
The following powerpoint presentation is about the current AF guidelines, prepared by Dr Jawad Siraj, who is a final year resident as Cardiology Unit, PGMI, LRH, Peshawar
Final presentation for my institutional APPE. I presented a full breakdown Cardiac Amyloidosis including clinical presentation, diagnosis and treatment options.
Cardiac arrhythmias occur frequently in ICU patients.
12% incidence of ventricular plus supra ventricular arrhythmias for a general icu population.
The most common arrhythmia is sinus tachycardia. Atrial arrhythmias also occur with some frequency , where as ventricular arrhythmias are less common but usually more ominous.
Not all arrhythmias seen in the ICU are of new onset , some patients have preexisting arrhythmias that can be exacerbated by their critical illness
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
2. DEFINITION
•PPCM is defined as the cardiac
failure occuring for the first time
in the last month of pregnancy or
within five months after
delivery.(WILLIAM OBSTETRICS
26th edition)
3.
4.
5. NORMAL CARDIAC FINDINGS
• Raised JVP with prominent pulsation
• Brisk and diffuse apical impulse, shifted upwards and
outwards
• Loud S1, S2 with widely split
• Occasional S3
• Aorto and Pulmonary flow murmur
• Mammary souffle
8. NYHA FUNCTIONAL
CLASSIFICATION OF CARDIAC
DISEASE
• Class1 – No symptoms or no limitation in ordinary physical
activity
• Class 2- Mild symptoms and slight limitation during ordinary
activity.
• Class3 – Marked limitation in activity due to symptoms even
during less than ordinary activity.
• Class4 –Severe limitations , symptoms even at rest.
9. DIAGNOSTIC CRITERIA
1. Absence of determinable cause of HF and absence of
existing heart disease.
2. HF for the first time in the last month of pregnancy or upto 5
months of post partum period.
3. Echocardiographic evidence of LV dysfunction demonstrated
by reduced EF <45%
• MAINLY A DIAGNOSIS OF EXCLUSION
10. INCIDENCE, RISK FACTORS &
GENERAL POINTS
• 1 IN 4000 pregnancies
• Women >30 yrs, black, multiparous.
• Women with pre eclampsia or HTN,smoker, malnourished.
• Can result in severe CHF
• Clinically present by 3rd trimester
• Close hemodynamic monitoring and early delivery may be
necessary
• Cardiomyopathy may persist even after delivery
• High rate of recurrence so birth control recommended
11.
12.
13.
14.
15.
16. SIGNS AND SYMPTOMS IN PPCM
V/S NORMAL PREGNANCY
NORMAL PREGNANCY
• FATIGUE
• TACHYCARDIA
• DYSPNEA
• PERIPHERAL EDEMA
PPCM
• FATIGUE
• TACHYCARDIA
• DYSPNEA
• PERIPHERAL EDEMA
• CHEST PAIN
• PND/ORTHOPNEA
17.
18. DIFFERENTIAL DIAGNOSIS OF
PERIPARTUM CARDIOMYOPATHY
MYOCARDITIS
PRE EXISTING IDIOPATHIC/FAMILIAL DILATED OR ACQUIRED
CARDIOMYOPATHY
TAKOTSUBO SYNDROME
PREGNANCY ASSOCIATED MYOCARDIAL INFARCTION
PULMONARY EMBOLISM
AMNIOTIC FLUID EMBOLISM
HYPERTENSIVE HEART DISEASE / SEVERE PRE ECLAMPSIA
HYPERTROPHIC CARDIOMYOPATHY
HIV/AIDS CMP
PRE EXISTING/UNKNOWN CHD
21. NORMAL WARD,
AMBULATORY TREATMENT IN
SELECTED PATIENTS POSSIBLE
INTERMEDIATE CARE INTENSIVE CARE
ORAL HF DRUGS DIURETICS I.V DIURETICS I.V
ORAL DIURETICS IN CASE OF
FLUID OVERLOAD
CONSIDER VASORELAXANTS IF
SBP>110 MMHG
MECHANICAL CIRCULATORY
SUPPORT
CONSIDER BROMOCRIPTINE
FOR 1 WEEK
SUPPLEMENTAL O2;NIV IF
NECESSARY
INVASIVE VENTILATION
AVOID
INOTROPES/CATECHOLAMINE
S
INOTROPES/CATECHOLAMINE
S IF NEEDED
CONSIDER BROMOCRIPTINE
FOR 8WEEKS IF LVEF<25%
CONSIDER BROMOCRIPTINE
FOR 8 WEELS,UPTITRATION
DEPENDS ON PROLACTIN
LEVEL
ORAL HEART FAILURE DRUGS ORAL HEART FAILURE DRUGS
AFTER STABILISATION
25. PROGNOSIS
• RESULTS OF IPAC study:
• Upto 72% women with PPCM have improvement in LVEF.
• But increased LV remodelling(LVEDD>6cm), black race, initial
LVEF <30% are poor prognostic factors.
26. RISK IN SUBSEQUENT PREGNANCIES IN
PPCM
• PPCM WITH PARTIALLY OR FULLY
RECOVERED LV FUNCTION(LVEF>50%)
• SUBSTANTIAL RISK OF RELAPSE WITH
SUBSEQUENT PREGNANCY
• RISK OF HEART FAILURE/DEATH(<10%)
• USUALLY GOOD FETAL OUTCOME
SPECIFIC MANAGEMENT:-
• PREGNANCY CAN CONTINUE BUT
SOME RISK REMAIN
• BROMOCRIPTINE-CONSIDER
POSTPARTUM
• ADMISSION TO HIGH CARE UNIT
IF IN DECOMPENSATED HEART
FAILURE
• PPCM WITH POORLY RECOVERED LV
FUNCTION (LVEF<50%)
• HIGH RISK OF RELAPSE WITH
SUBSEQUENT PREGNANCY .RISK OF
HEART FAILURE/DEATH (>10%)
• RISK OF PREMATURE DELIVERY
• RISK OF FETAL DEATH
• SPECIFIC MANAGEMENT:-
• SHOULD ADVISE AGAINST
PREGNANCY ESPECIALLY IF
LVEF<30%
• BOARD:-
• Bromocritine-strongly consider
postpartum
• Oral heart failure drugs
• Anticoagulation
• Relaxants-vasodilators
• Diuretics
29. LENGTH OF TREATMENT FOR
PATIENTS WITH PPCM WITH
RECOVERED LVEF
• Treatment is recommended for at least 12 months after
recovery of both the left ventricular EF & dimensions.
• A period of time without medication and with recurrent
echocardiograms is ideal for confirming that the EF does not
deteriorate before a decision regarding a new pregnancy.